Tag: Dialogue

After a leukemia diagnosis, two-year-old Noah Ludgood joined a clinical trial for a promising immunotherapy treatment, which was possible because of the advanced expertise at UR Medicine's Golisano ...

“What’s going on over there?” Mike Delooze wondered. He has stage 4 lung cancer and saw the WCI Webster building going up not far from his workplace. He is grateful for the care he's able to receive ...

Their experience shifted career goals toward Wilmot patients.

So you're ready to give up smoking. Now what? UR Medicine and Wilmot Cancer Institute tobacco cessation experts offer some tips.

Patients who have colorectal cancer that has spread to the liver come from all over the U.S. to have living-donor liver transplants at the University of Rochester Medical Center. A new report shows ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the ...

It was college spring break week at the University of Rochester in 1976 for John Saunders, but there would be no fun outings, no hanging out. He had just learned he had Hodgkin lymphoma. He shares ...

Fifty years ago, the University of Rochester established its cancer center, around the time the nation's view of the disease began to change. Today, cancer research and treatment is in its most ...

The latest edition of Dialogue magazine from the Wilmot Cancer Institute is about progress, gratitude, and achievement, as the cancer center reaches its 50-year milestone.

Sarah Moore’s life over the past year has been mind-boggling and, at the same time, miraculous, after she spent more than 200 days in the hospital at Wilmot Cancer Institute.